Eurofins BioPharma Services Newsletter 31 - Febbraio 2022

Eurofins presenta la nuova edizione della newsletter BioPharma NEWS. 
Articoli contenuti:

• Eurofins BPT Toronto expands psychedelics testing and certification services to support mental health therapies
• Eurofins CDMO helps solve the rising challenge of colon drug delivery for biologics
• Organoids: the next step in precision oncology
• The future of drug discovery: E3scanTM and beyond
• Eurofins BPT Italy expands biologics testing capacity with new fully operational BSL2 facility
• Eurofins Central Laboratory solves PBMC processing challenges in global clinical trials

Scarica la newsletter in versione PDF

Cordiali saluti

Il comitato editoriale del gruppo Eurofins.